TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.

Andrew W Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.